研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章 · 第 6 页
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-09-23 到 2026-09-11。
按期刊、按主题看 →
SiM Clinical Trials Causal Inference · 发表于 2026-09-23,收录于 2026-10-20
Bryan S Blette, Zhe Chen, Brennan C Kahan, Andrew Forbes, Michael O Harhay, Fan Li
摘要
In cluster randomized trials, the individual-average treatment effect (i-ATE) can be different from the cluster-average treatment effect (c-ATE) when informative cluster size (ICS) is present, that is, when treatment effects or participant outcomes depend on cluster size. In such scenarios, mixed-effects models and generalized estimating equations (GEEs) with exchangeable correlation structure are biased for both the i-ATE and c-ATE estimands, whereas GEEs with an independence correlation structure or analyses of cluster-level summaries are recommended in practice. However, when cluster size is non-informative, mixed-effects models and GEEs with exchangeable correlation structure can provide unbiased estimation and notable efficiency gains over other methods. Thus, hypothesis tests for ICS would be useful to assess this key phenomenon under cluster randomization. In this work, we develop model-based, model-assisted, and randomization-based tests for ICS in cluster randomized trials. We conduct simulation studies to examine the operating characteristics of these tests, show they have appropriate Type I error rate control and meaningful power, and contrast them to existing model-based tests used in the observational study setting. The proposed tests are then applied to data from a recent cluster randomized trial, and practical recommendations for using these tests are discussed.
Biometrika Clinical Trials Nonparametric & Semiparametric · 发表于 2026-09-23,收录于 2026-09-24
Q Zhou, K Y Wong
摘要
Summary: Two-phase sampling is commonly adopted for reducing cost and improving estimation efficiency. In many two-phase studies, the outcome and some cheap covariates are observed for a large sample in Phase I, and expensive covariates are obtained for a selected subset of the sample in Phase II. As a result, the analysis of the association between the outcome and covariates faces a missing data problem. Complete-case analysis, which relies solely on the Phase II sample, is generally inefficient. In this paper, we study a two-step estimation approach, which first obtains an estimator using the complete data, and then updates it using an asymptotically mean-zero estimator obtained from a working model between the outcome and cheap covariates using the full data. This class of two-step estimators are asymptotically at least as efficient as the complete-data estimator and are robust to misspecification of the working model. We propose a kernel-based method to construct a two-step estimator that achieves optimal efficiency within this class of estimators. Additionally, we develop a simple joint update approach based on multiple working models to approximate the optimal estimator when a fully nonparametric kernel approach is infeasible. We illustrate the proposed methods with various outcome models. We demonstrate their advantages over existing approaches through simulation studies and provide an application to a major cancer genomics study.
SiM Machine Learning Longitudinal Data · 发表于 2026-09-23,收录于 2026-10-08
Kiana Farhadyar, Maren Hackenberg, Kira Ahrens, Charlotte Schenk, Bianca Kollmann, Oliver Tüscher, Klaus Lieb, Michael M. Plichta, Andreas Reif, Raffael Kalisch, Martin Wolkewitz, Moritz Hess, Harald Binder
摘要
*(publisher's abstract as deposited in Crossref, verbatim)* Modeling of longitudinal cohort data typically involves complex temporal dependencies between multiple variables. There, the transformer architecture, which has been highly successful in language and vision applications, allows us to account for the fact that the most recently observed time points in an individual's history may not always be the most important for the immediate future. This is achieved by assigning attention weights to observations of an individual based on a transformation of their values. One reason why these ideas have not yet been fully leveraged for longitudinal cohort data is that typically, large datasets are required. Therefore, we present a simplified transformer architecture that retains the core attention mechanism while reducing the number of parameters to be estimated, to be more suitable for small datasets with few time points. Guided by a statistical perspective on transformers, we use an autoregressive model as a starting point and incorporate attention as a kernel‐based operation with temporal decay, where aggregation of multiple transformer heads, that is, different candidate weighting schemes, is expressed as accumulating evidence on different types of underlying characteristics of individuals. This also enables a permutation‐based statistical testing procedure for identifying contextual patterns. In simulation studies, including a controlled simulation on real clinical predictor data, the approach is shown to recover contextual dependencies even with a small number of individuals and time points. In an application to data from a resilience study, we identify temporal patterns in the dynamics of stress and mental health. This indicates that properly adapted transformers can not only achieve competitive predictive performance, but also uncover complex context dependencies in small data settings.
JASA Testing & Uncertainty Optimization & Learning Theory · 发表于 2026-09-22
Yajie Bao, Yang Hu, Haojie Ren, Peng Zhao, Changliang Zou
摘要
In decision-making under uncertainty, Contextual Robust Optimization (CRO) provides reliability by minimizing the worst-case decision loss over a prediction set. While recent advances use conformal prediction to construct prediction sets for machine learning models, the downstream decisions critically depend on model selection. This paper introduces novel model selection frameworks for CRO that unify robustness control with decision risk minimization. We first propose Conformalized Robust Optimization with Model Selection (CROMS), a framework that selects the model to approximately minimize the averaged decision risk in CRO solutions. Given the target robustness level 1−α, we present a computationally efficient algorithm called E-CROMS, which achieves asymptotic robustness control and decision optimality. To correct the control bias in finite samples, we further develop two algorithms: F-CROMS, which ensures a 1−α robustness but requires searching the label space; and J-CROMS, which offers lower computational cost while achieving a 1−2α robustness. Furthermore, we extend the CROMS framework to the individualized setting, where model selection is performed by minimizing the conditional decision risk given the covariates of the test data. This framework advances conformal prediction methodology by enabling covariate-aware model selection. Numerical results demonstrate significant improvements in decision efficiency across diverse synthetic and real-world applications, outperforming baseline approaches. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2026-09-22
Jianqing Fan, Jikai Hou, Mengxin Yu
摘要
This paper addresses the item ranking problem with associated covariates, focusing on scenarios where the preference scores can not be fully explained by covariates, and the remaining intrinsic scores are sparse. Specifically, we extend the pioneering Bradley-Terry-Luce (BTL) model by incorporating covariate information and considering sparse individual intrinsic scores. Our work introduces novel model identification conditions and examines the statistical rates of the regularized penalized Maximum Likelihood Estimator (MLE). We then construct a debiased estimator for the penalized MLE and analyze its distributional properties. Additionally, we apply our method to the goodness-of-fit test for models with no latent intrinsic scores, namely, the covariates fully explaining the preference scores of individual items. We also offer confidence intervals for ranks. Our numerical studies lend further support to our theoretical findings, demonstrating validation for our proposed method. *(abstract via OpenAlex)*
JASA Other · 发表于 2026-09-22
Yu Tan, Yongxiang Li, Xiaowu Dai, Kwok-Leung Tsui
摘要
Functional ANOVA (FANOVA) is a widely used variance-based sensitivity analysis tool. However, studies on functional-output FANOVA remain relatively scarce, especially for black-box computer experiments, which often involve complex and nonlinear functional-output relationships with unknown data distributions. Conventional approaches often rely on predefined basis functions or parametric structures that lack the flexibility to capture complex nonlinear relationships. Additionally, strong assumptions about the underlying data distributions further limit their ability to achieve data-driven orthogonal effect decomposition. To address these challenges, this study proposes a functional-output orthogonal additive Gaussian process (FOAGP) to efficiently perform data-driven orthogonal effect decomposition. By enforcing a conditional orthogonality constraint on the separable prior process, the proposed functional-output orthogonal additive kernel enables data-driven orthogonality without requiring prior distributional assumptions. The FOAGP framework also provides analytical formulations for local Sobol’ indices and expected conditional variance sensitivity indices, enabling comprehensive sensitivity analysis by capturing both global and local effect significance. Validation through simulation studies and a real case study on fuselage shape control confirms the model’s effectiveness in orthogonal effect decomposition and variance decomposition, demonstrating its practical value in engineering applications. *(abstract via OpenAlex)*
Biometrika Survival Analysis Clinical Trials · 发表于 2026-09-22,收录于 2026-09-24
Jinghao Sun, Douglas E Schaubel, Eric J Tchetgen Tchetgen
摘要
*(publisher's abstract as deposited in Crossref, verbatim)* Restricted mean survival time offers a compelling nonparametric alternative to hazard ratios for right-censored time-to-event data, particularly when the proportional hazards assumption is violated. By capturing the total event-free time over a specified horizon, it provides an intuitive and clinically meaningful measure of absolute treatment benefit. Nonetheless, selecting the restriction time poses challenges: choosing a small restriction time may overlook late-emerging benefits, while a large one can inflate variance and reduce power, an issue whose impact on the precision of inference is often underappreciated. We propose a novel data-driven, adaptive procedure that identifies the optimal restriction time from a continuous range by maximizing a criterion balancing effect size and estimation precision. Consequently, our procedure is particularly powerful when the pattern of the treatment effect is unknown at the design stage. We provide a rigorous theoretical foundation that accounts for the additional variability introduced by adaptive selection. To address nonregular estimation under the null, we develop two complementary strategies: a convex-hull-based estimator, and a penalized approach that regularizes restriction-time selection. Additionally, when restriction time candidates are pre-specified on a discrete grid, our procedure has the same first-order distribution as an oracle estimator evaluated at the penalized population optimizer, with no additional first-order variance from selection. Extensive simulations across realistic survival scenarios demonstrate that our method outperforms traditional restricted mean survival time analyses and the log-rank test, achieving superior power while maintaining approximately nominal type I error rates. In a phase III pancreatic cancer trial with transient treatment effects, our procedure uncovers clinically meaningful benefits that standard methods overlook. Software implementing the methods is available in the package AdaRMST.
JASA Bayesian Methods Spatial & Time Series Genetics & Omics · 发表于 2026-09-22
Meng Zhou, Shuangge Ma, Mengyun Wu
摘要
Spatial transcriptomics measures gene expression alongside the spatial coordinates of each capture spot or cell across tissue samples. The detection of spatially variable (SV) genes, whose expression exhibits systematic spatial variation, enables the delineation of functional tissue domains and the identification of region-specific transcriptional changes that underlie disease heterogeneity. However, empirical evidence from spatial transcriptomics data indicates that existing methods are hindered by two practical issues: reliance on predefined spatial patterns that often miss tissue complexity, and a lack of standardized approaches for multi-sample integration, which undermines reproducibility and biological interpretability. To address these issues, we propose a novel integrated Bayesian hierarchical model that combines flexible nonparametric spatial modeling with information sharing across samples. The model uses an adaptive spatial process that can capture a wide range of spatial patterns while remaining interpretable. We also introduce a new prior that borrows strength across samples, enabling robust detection of SV genes from multiple tissue sections. An efficient variational approximation is developed for scalable posterior computation. Analyzing spatial transcriptomics data from human brain and skin cancer tissues, our framework identifies spatially structured SV genes, enabling the delineation of tissue domains and the discovery of functionally coherent gene clusters through pathway enrichment analysis. *(abstract via OpenAlex)*
SiM Survival Analysis Bayesian Methods · 发表于 2026-09-22
Richard A. Chechile, Daniel H. Barch
摘要
A new Bayesian distribution‐free medical survivor analysis is presented that strictly avoids using right‐tail censored data. The Bayesian procedure is focused on two population parameters called and , which are separate metrics of a treatment difference between the two conditions. The parameter is the proportion of failures that are from the Control condition, and the parameter is a stochastic difference measure associated with longer survival time before a failure for the patients in the Experimental condition. Point and interval estimates along with a Bayes factor are provided for both parameters. Software is provided for implementing the Bayesian analysis. Monte Carlo simulations are also developed to study the interplay between the stop‐testing time used in survival analysis with other variables such as effect size and sample size. The simulations also provide information that enable an approach to survival analysis where there is an early decision about the relative effectiveness of the treatments that is based on the Bayes factor value associated with the statistic. This decision can be made when there is a high proportion of right‐tail censored data. In the limit of times so long that there are all failures—thus no right‐tail censoring—the metric is not informative, but the metric is still a valid measure of the stochastic difference in failure times between the two conditions.
Biometrika Causal Inference Nonparametric & Semiparametric · 发表于 2026-09-21,收录于 2026-09-24
Jiewen Liu, Chan Park, Yonghoon Lee, Yunshu Zhang, Mengxin Yu, James M Robins, Eric J Tchetgen Tchetgen
摘要
*(arXiv preprint abstract, arXiv:2507.09302, verbatim; the journal version may differ)* The instrumental variable (IV) design is a common approach to address hidden confounding bias. For validity, an IV must impact the outcome only through its association with the treatment. In addition, IV identification has required a homogeneity condition such as monotonicity or no unmeasured common effect modifier between the additive effect of the treatment on the outcome, and that of the IV on the treatment. In this work, we introduce the Multiplicative Instrumental Variable Model (MIV), which encodes a condition of no multiplicative interaction between the instrument and an unmeasured confounder in the treatment propensity score model. Thus, the MIV provides a novel formalization of the core IV independence condition interpreted as independent mechanisms of action, by which the instrument and hidden confounders influence treatment uptake, respectively. As we formally establish, MIV provides nonparametric identification of the population average treatment effect on the treated (ATT) via a single-arm version of the classical Wald ratio IV estimand, for which we propose a novel class of estimators that are multiply robust and semiparametric efficient. Finally, we illustrate the methods in extended simulations and an application on the causal impact of a job training program on subsequent earnings.
Biometrics Causal Inference · 发表于 2026-09-21,收录于 2026-09-24
Hongzi Li, Wei Ma, Yingying Ma, Hanzhong Liu
摘要
Randomized experiments are the gold standard for investigating causal relationships, with comparisons of potential outcomes under different treatment groups used to estimate treatment effects. However, outcomes with heavy-tailed distributions pose significant challenges to traditional causal inference approaches. While recent studies have explored these issues under simple randomization, their application in more complex randomization designs, such as stratified randomization or covariate-adaptive randomization, has not been adequately addressed. To fill the gap, we first investigate the performance of nonparametric kernel density estimation methods under covariate-adaptive randomization, thereby establishing theoretical guarantees for treatment effect estimators based on the estimated densities. Second, we demonstrate the application of our density estimation framework to estimate the density treatment effect and overall quantile treatment effect, deriving the consistency and asymptotic normality of the estimators. For the overall quantile treatment effect, we show that the existing variance estimator for the influence function-based M-estimator tends to overestimate the asymptotic variance, especially under more balanced designs, and lacks universal applicability across randomization methods. To remedy this, we introduce a novel stratified transformed difference-in-means estimator to enhance efficiency and propose a universally applicable variance estimator to facilitate valid inferences. Numerical results demonstrate the effectiveness of the proposed methods in finite samples.
Biometrics Causal Inference Latent Variables & Mixtures Longitudinal Data · 发表于 2026-09-21,收录于 2026-09-24
Jiaxi Wu, Alexander Franks
摘要
Unmeasured confounding can severely bias causal effect estimates from spatiotemporal observational data, especially when the confounders do not vary smoothly in time and space. In this work, we develop a method for addressing unmeasured confounding in spatiotemporal contexts by building on models from the panel data literature and methods in multivariate causal inference. Our method is based on a factor confounding assumption, which posits that effects of unmeasured confounders on exposures and outcomes can be captured by a shared latent factor model. Factor confounding is sufficient to partially identify causal effects, even when there is interference between units. Additional assumptions that limit the degree of spatiotemporal interference, reasonable in most applications, are sufficient to point-identify the effects. Simulation studies demonstrate that the proposed approach can substantially reduce omitted variable bias relative to other spatial smoothing and panel data baselines. We illustrate our method in a case study of the effect of prenatal $\text{PM}_{2.5}$ exposure on birth weight in California.
SiM Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2026-09-21
Martin Geroldinger, Martin Laimer, Verena Wally, Johann W. Bauer, Georg Zimmermann
摘要
Multivariate endpoints are increasingly used in clinical studies on rare diseases, where sample sizes tend to be small and distributional assumptions are often violated. In such settings, commonly applied parametric multivariate methods, such as classical MANOVA approaches, may suffer from inflated type‐I error or reduced statistical power. Therefore, a neutral simulation‐based comparison of four methodologically different approaches for the analysis of multivariate outcomes in parallel group designs was conducted. The four approaches included the nonparametric R package npmv (using permutation and randomization resampling for small samples), a semiparametric MANOVA approach from the R package MANOVA.RM with both a Wald‐type statistics (WTS) and a modified ANOVA‐type statistics (MATS) using all available variants including also bootstrap approaches, a classical parametric MANOVA , and multiple univariate Mann–Whitney tests with Holm correction. The simulation framework was informed by empirical distributions derived from anonymized clinical data and clinical expert guidance. Two clinically realistic effect types were mainly evaluated: (i) percent‐responder effects for wound size reduction and (ii) additional location shifts in pain and pruritus visual analog scales (VAS) scores. In addition, scenarios are examined in which classical assumptions such as multivariate normality and homogeneity of covariance matrices are violated. The sample sizes considered ranged from 12 to 360 subjects. Both balanced and unbalanced designs were evaluated, with the objective of illustrating potential limitations of methods when applied to small samples. Outcomes were assessed in terms of type‐I error control and statistical power. Overall, npmv , the MATS using especially parametric bootstrap within the semiparametric MANOVA.RM package maintained reliable type‐I error control, whereas the semiparametric MANOVA.RM approach with the WTS using its asymptotic approximation showed very liberal type‐I error behavior to almost no type‐I error control in small sample scenarios, and especially in unbalanced settings. Bootstrap approaches especially of the WTS substantially improved type‐I error control compared with the asymptotic WTS. The nonparametric npmv approach achieved good power values, especially in small samples, as did the modified ATS approach using parametric bootstrap from the MANOVA.RM package, which achieved very similar results. The univariate Mann–Whitney U test with Holm correction tended to yield conservative results for small samples; however, despite the univariate nature of this approach, it achieved a high and comparable level of statistical power in many scenarios. Classical MANOVA also yielded good results in certain scenarios; however, it exhibited rather liberal type‐I error rates, primarily in heteroscedastic scenarios and unbalanced designs, which can be explained by a violation of the assumption of homoscedastic covariance matrices. These results highlight the strengths and limitations of a multi‐aspect analysis in parallel group designs especially for small sample settings, as common in rare diseases, and provide guidance for the analysis in rare disease research.
SMMR Causal Inference High-Dimensional Survival Analysis · 发表于 2026-09-19
Chien-Lin Su
摘要
Clinical trials and observational studies frequently encounter survival data with right censoring and high-dimensional confounders. This article proposes several estimators for assessing the average causal effect of a binary treatment on survival outcomes in the presence of confounders. These include doubly weighted estimators, regression model-based estimators, and doubly robust estimators. The proposed doubly robust estimators are shown to be consistent when either the treatment model or the semiparametric regression model for survival outcomes is correctly specified. A variable selection technique based on an adaptive sparse group lasso regularization approach is proposed to identify important confounders among high-dimensional covariates for both treatment and outcome models. This method enables simultaneous variable selection and regularization for both models. The performance of the proposed methodologies is thoroughly evaluated through simulation studies. Finally, the practical utility of the proposed methods is illustrated through applications to two real-world datasets.
Biometrics Survival Analysis · 发表于 2026-09-18
Sumonkanti Das, Robert G Clark, Mahdi Parsa, Belinda Barnes
摘要
Many countries screen import consignments to guard against the entry of exotic pests, contaminants, and pathogens. A widely used strategy is to pool individual units into groups and test each group for presence or absence of contamination. Consignments are typically rejected if there are any detections. Screening samples are commonly designed to give a high chance of detection assuming a design prevalence. What is less common, however, is to analyze the history of testing outcomes to infer how many accepted consignments contain contaminated units, and the number of contaminated units—jointly referred to as “leakage.” We build on existing censored beta-binomial models to answer these questions for the importation of frozen seafood into Australia, allowing for unknown test sensitivity and specificity. We present new theory and empirical results demonstrating that specificity is identifiable from test data in this context, but sensitivity is not. We also develop a new class of models in which consignment propensity is either zero or above a minimum positive prevalence threshold, motivated by our case study but applicable more widely. Past testing data are modeled under multiple scenarios using both hierarchical Bayes and maximum likelihood methods, revealing new insights into the risk of leakage.
SiM Missing Data & Measurement Error Bayesian Methods · 发表于 2026-09-18
Madeleine E. St. Ville, Yaeji Lim, Ruijin Lu, Katherine L. Grantz, Zhen Chen
摘要
We develop a Bayesian Additive Regression Trees with Measurement Error (BART‐ME) model for flexibly estimating exposure‐response functions when multiple covariates are measured with classical error. Unlike existing approaches, BART‐ME accommodates nonlinearities, interactions, correlated exposures, and correlated measurement errors, while exploiting replicate measurements to estimate the error variance‐covariance structure. Posterior inference is obtained via a Metropolis‐within‐Gibbs algorithm, yielding estimates of exposure‐response functions, variable importance, and measurement reliability. Simulation studies demonstrate that BART‐ME reduces bias and improves coverage compared with Naïve BART analyses that ignore measurement error, even with sparse replication. In an application to first‐trimester ultrasound data from the NICHD Fetal Growth Studies, BART‐ME identified crown‐rump length as the most reliable predictor of gestational age at delivery and revealed nonlinear patterns attenuated by Naïve methods. These results illustrate the potential of BART‐ME as a general framework for correcting measurement error in complex exposure settings.
Biometrics Latent Variables & Mixtures Nonparametric & Semiparametric Bayesian Methods · 发表于 2026-09-18,收录于 2026-09-24
Yuliang Xu, Kaixuan Luo, Li Ma
摘要
Modeling multiple sampling densities within a hierarchical framework enables borrowing of information across samples. These "density random effects" can act as kernels in latent variable models to represent exchangeable subgroups or clusters. A key feature of these kernels is the (functional) covariance they induce, which determines how densities are grouped in mixture models. Our motivating problem is clustering chromatin accessibility profiles from high-throughput DNase-seq experiments to detect transcription factor (TF) binding. TF binding typically produces footprint profiles with spatial patterns, creating long-range dependency across genomic locations. Existing nonparametric hierarchical models impose restrictive covariance assumptions and cannot accommodate such dependencies, often leading to biologically uninformative clusters. We propose a nonparametric density kernel that is flexible enough to capture diverse covariance structures and adapts to various spatial patterns of TF footprints. The kernel specifies dyadic tree splitting probabilities via a multivariate logit-normal model with a sparse precision matrix. Bayesian inference for latent variable models using this kernel is implemented through Gibbs sampling with Pólya–Gamma augmentation. Extensive simulations show that our kernel substantially improves clustering accuracy. We apply the proposed mixture model to DNase-seq data from the Encyclopedia of DNA Elements project, which results in biologically meaningful clusters corresponding to binding events of two common TFs.
Econometrica Econometrics & Economics · 发表于 2026-09-17
Lauren Falcao Bergquist, Benjamin Faber, Thibault Fally, Matthias Hoelzlein, Edward Miguel, Andres Rodriguez-Clare
摘要
Policies to raise agricultural productivity have been central in the fight against global poverty. Their impacts are often measured in experiments that provide strong causal identification but may be too small-scale to capture general equilibrium effects that arise when policies are scaled up. We develop a quantitative model of agricultural trade, featuring a granular economic geography, that combines parameters estimated from small-scale experiments with rich administrative microdata to quantify how treatment effects change when policies are scaled up. Applying this framework to input subsidies in Uganda, we find that average welfare gains fall by about 20% when implemented at scale. However, gains increase among the poorest households, as returns shift from land to labor, reducing the regressivity of the intervention by more than half. We examine how these forces vary with household and market characteristics and the geographic scale of implementation, with implications for randomized saturation designs." (Retrieved from the Econometric Society's Forthcoming Papers listing; Wiley Early View blocked.) *Publication/online date: date unknown*
AoS Causal Inference · 发表于 2026-09-17
Peng Ding, Zhichao Jiang
摘要
Crossover designs randomly assign each unit to receive a sequence of treatments. By comparing outcomes within the same unit, these designs can effectively eliminate between-unit variation and facilitate the identification of both instantaneous effects of current treatments and carryover effects from past treatments. They are widely used in traditional biomedical studies and are increasingly adopted in modern digital platforms. However, standard analyses of crossover designs often rely on strong parametric models, making inference vulnerable to model misspecification. This paper adopts a design-based framework to analyze general crossover designs. We make two main contributions. First, we use potential outcomes to formally define the causal estimands and assumptions on the data-generating process. For any given type of crossover design and assumptions on potential outcomes, we outline a procedure for identification and estimation, emphasizing the central role of the treatment assignment mechanism in design-based inference. Second, we unify the analysis of crossover designs using least squares, with restrictions on the coefficients and weights on the units. Based on the theory, we recommend the specification of the regression function, weighting scheme, and coefficient restrictions to assess identifiability, construct efficient estimators, and estimate variances in a unified fashion. Crucially, the least squares procedure is simple to implement, and yields not only consistent and efficient point estimates but also valid variance estimates even when the working regression model is misspecified." *Publication/online date: date unknown (IMS Future Papers list gives no per-item date)*
SiM Clinical Trials Missing Data & Measurement Error Survival Analysis · 发表于 2026-09-17
Ruben P. A. van Eijk, Ying Lu
摘要
Generalized pairwise comparisons are increasingly being used in randomized clinical trials. This study evaluates how missing data strategies impact the operating characteristics of endpoints combining overall survival and a longitudinal outcome. A simulation study was conducted to evaluate the impact of censoring and missing longitudinal data on the Type I error, power, and bias of a hierarchical composite endpoint. Seven missing data strategies were identified from the literature, including assigning ties to missing patient pairs, comparing patients at their last common visit, and applying multiple imputation. Conditional longitudinal and survival data were generated based on the natural history of amyotrophic lateral sclerosis. Simulation scenarios varied in censoring rates, extent of missing longitudinal data, differential attrition between treatment arms, and the dependency of missingness on disease severity. All methods were unbiased and maintained nominal Type I error when censoring and missingness were balanced across treatment arms. Under imbalance, however, Type I error increased—reaching up to 0.378 for some strategies. The last common visit strategy was the only approach that consistently preserved nominal error rates (0.025 ± 0.002). Regarding statistical power, all methods exhibited a loss of precision and increased bias under the alternative hypothesis as missingness increased. Multiple imputation partially recovered power and reduced bias but inflated the Type I error rate in scenarios with differential attrition. As generalized pairwise comparisons are increasingly used in pivotal clinical trials—and therefore in regulatory contexts—our findings provide practical guidance for selecting a robust primary analysis strategy and minimizing bias arising from incomplete data.
Econometrica Other 讨论 / 评论 · 发表于 2026-09-17
Emilia Tjernström, Dalia Ghanem, Aleksandr Michuda, Oscar Barriga-Cabanillas, Travis J. Lybbert, Jeffrey D. Michler
摘要
This paper illustrates and addresses weak identification in the correlated random coefficient (CRC) model that Suri (2011) uses to study agricultural technology adoption. Using the publicly available dataset, which differs slightly from the version used in Suri (2011), we obtain different point estimates for the paper's main CRC model. To understand why these differences are as large as they are, we recast the CRC model as a more general random coefficient model in which the returns to hybrid adoption are restricted to be linear in comparative advantage. This reveals that the key structural parameter in the CRC model (φ), which governs the relationship between baseline productivity and the returns to adoption, is prone to a weak identification problem. We then propose a procedure to conduct weak-identification robust inference on φ using test inversion. Our weak-identification robust confidence intervals contain the original Suri (2011) point estimates, which suggests that the difference in results may be attributable to a combination of minor data differences and weak identification." (Retrieved from the Econometric Society's Forthcoming Papers listing; Wiley Early View blocked.) *Publication/online date: date unknown*
Econometrica Networks & Graphs · 发表于 2026-09-17
Erin M. Kelley, Manzoor H. Dar, Alain de Janvry, Kyle Emerick, Elisabeth Sadoulet
摘要
A key policy goal is to ensure that information about new technologies reaches as many people as possible. While social networks can aid in information diffusion, identifying the most influential individuals is often costly. In a randomized controlled trial in Bangladesh, we test an alternative approach. We provide a randomly selected group of farmers with a new rice variety and ask them to establish demonstration plots—where the new variety is planted alongside an existing one for public viewing—to encourage communication among individuals who may not typically interact and facilitate knowledge sharing. We find that demonstration plots raise awareness and learning among other farmers in the village just as effectively as the standard approach of targeting network-central individuals. We further show that demonstration plots effectively turn ordinary farmers into information broadcasters, reaching less connected individuals and removing the need to identify key influencers within the network." (Retrieved from the Econometric Society's Forthcoming Papers listing; Wiley Early View blocked.) *Publication/online date: date unknown*
Biometrika Optimization & Learning Theory Causal Inference · 发表于 2026-09-17,收录于 2026-09-24
Dennis Shen, Dogyoon Song, Peng Ding, Jasjeet Sekhon
摘要
Summary: Recent advances in deep learning have highlighted the phenomenon of benign overfitting in overparameterized statistical models, sparking significant interest in understanding its foundations. Owing to its simplicity and practical relevance, the ordinary least-squares interpolator has become a key object of study for gaining theoretical insight into this phenomenon. While the properties of ordinary least squares are well understood in classical underparameterized settings, its behaviour in the overparameterized regime, unlike that of ridge regression or the lasso, remains comparatively less explored. We contribute to this growing literature by deriving new algebraic and statistical results for the minimum $ \ell_{2} $-norm ordinary least-squares interpolator. In contrast to much of the existing work, which focuses on prediction risk, we centre our analysis on parameter estimation and inference, which are fundamental to many statistics and causal inference applications. Specifically, we establish overparameterized analogues of (i) the leave-$ k $-out formulas, (ii) the omitted-variable bias formula and (iii) the Frisch–Waugh–Lovell theorem. Under the Gauss–Markov model, we further extend the Gauss–Markov theorem and analyse variance estimation under homoscedasticity in the overparameterized setting. Collectively,these results provide a systematic framework for studying parameter estimation and inference in overparameterized linear models, offering a novel perspective on benign overfitting beyond its implications for prediction.
Econometrica Other · 发表于 2026-09-17
Guillaume A. Pouliot
摘要
Multivariate linear regression and randomization-based inference are two essential methods in statistics and econometrics. Nevertheless, the problem of producing a randomized test for the value of a single regression coefficient that is exactly valid when errors are exchangeable, and which is asymptotically valid for the best linear predictor, has remained elusive. In this paper, we produce a test that is exactly valid with exchangeable errors and which allows for general covariate designs; covariates may be continuous as well as discrete and may be correlated. The test is asymptotically valid when the errors are not exchangeable, in particular in the presence of conditional heteroskedasticity." (Retrieved from the Econometric Society's Forthcoming Papers listing; Wiley Early View blocked.) *Publication/online date: date unknown*
Econometrica Econometrics & Economics · 发表于 2026-09-17
Pietro Emilio Spini
摘要
This paper studies the robustness of estimated policy effects to changes in the distribution of covariates, a key determinant of the external validity of (quasi)-experimental results. I propose a novel robustness metric δ∗ which measures the smallest covariate shift needed to invalidate an empirical claim about the policy effect (e.g., ATE > 0). I estimate δ∗ via de-biased GMM, achieving a parametric rate of convergence while accommodating machine-learning estimators of treatment-effect heterogeneity (e.g., LASSO, random forests, neural networks). I develop benchmarking and calibration exercises to interpret the magnitude of δ∗. I illustrate these tools in an application to the Oregon Health Insurance Experiment. Researchers can report δ∗ alongside point estimates and standard errors as a third number gauging external validity under covariate shifts." (Wiley's Early View page for Econometrica was blocked; retrieved from the Econometric Society's own "Forthcoming Papers" listing, the official pre-issue source for accepted Econometrica papers.) *Publication/online date: date unknown (no date published on the Forthcoming Papers listing)*
Biometrics Clinical Trials Optimization & Learning Theory · 发表于 2026-09-16,收录于 2026-09-24
Rebecca B Silva, Bin Cheng, Shing M Lee
摘要
Project Optimus, an initiative by the FDA’s Oncology Center of Excellence, seeks to reform the dose-optimization and dose-selection paradigm in oncology. We propose a dose-optimization design that considers plateau efficacy profiles, integrates pharmacokinetic data to inform the exposure-toxicity curve, and accounts for patient characteristics that may contribute to heterogeneity in response. The dose-optimization design is carried out in two stages. First, a toxicity-driven stage estimates a safe set of doses. Then, a dose-ranging efficacy-driven stage explores the set using response and patient characteristic data, employing Bayesian Sparse Group Selection to understand patient heterogeneity. Between stages, the design integrates pharmacokinetic data and uses futility assessments to identify the target population among the general phase I patient population. An optimal dose is recommended for each identified subpopulation within the target population. The simulation study demonstrates that a model-based approach to identifying the target population can be effective; patient characteristics relating to heterogeneity were identified, and different optimal doses were recommended for each identified target subpopulation. Most designs that account for patient heterogeneity are intended for trials where heterogeneity is known, and pre-defined subpopulations are specified. However, given the limited information at such an early stage, subpopulations should be learned through the design.
Biometrics Survival Analysis Nonparametric & Semiparametric · 发表于 2026-09-16,收录于 2026-09-24
Shiro Tanaka, Thomas H Scheike
摘要
In competing-risks analysis, modeling each cause separately may yield specification of cumulative incidence functions that are not jointly coherent, because the resulting cause-specific probabilities need not satisfy the natural sum-to-one constraint. We address this problem by introducing a direct polytomous regression approach that models all causes jointly and enforces coherence through a reparameterization based on polytomous log-odds products. Our approach is applicable to semiparametric models with common multiplicative effects over time as well as models focused on a specific time point. For estimation under right-censoring, we develop stratified inverse probability of censoring weighted (IPCW) estimators for the effect parameters. Within a specified class of augmented IPCW estimators, the proposed estimators attain the minimum asymptotic variance under the stated regularity conditions, without the computational burden of deriving augmentation terms for each cause. The utility of our coherent modeling is demonstrated through simulation studies and its applications to a cohort study of type 2 diabetes and a randomized trial of prostate cancer.
Biometrics Causal Inference · 发表于 2026-09-16,收录于 2026-09-24
Kendrick Li, Xu Shi, Wang Miao, Eric Tchetgen Tchetgen
摘要
Outcome-dependent sampling is widely used in epidemiological and socioeconomic research to efficiently and economically study the treatment-outcome relationship. However, skepticism about unmeasured confounding bias and selection bias poses challenges for causal inference. In particular, a hidden common cause of the treatment, outcome, and sample selection process will generally induce both (a) unmeasured confounding, and (b) selection bias, thus rendering standard causal parameters unidentifiable without additional assumptions. In this article, we review and extend a recently proposed proximal causal inference approach for test-negative design studies to general outcome-dependent sampling designs, which leverages a pair of proxies of hidden factors at the source of unmeasured confounding and selection bias to jointly correct for both biases. Our contributions include: (i) a new set of conditions for the proximal identification of a causal odds ratio parameter when (a) and (b) co-exist; and (ii) a characterization of new proximal doubly robust estimators for the odds ratio effect under (a) and (b). We illustrate the performance of our estimators through extensive simulations and data from an application to University of Michigan Health System.
JASA Spatial & Time Series Networks & Graphs · 发表于 2026-09-14
Wenyang Liu, Ganggang Xu, Jianqing Fan, Xuening Zhu
摘要
We propose a two-way grouped network quantile (TGNQ) autoregression model for time series data observed on networks with substantial heterogeneity and complex directional interactions. Motivated by prior studies on network effects in directed networks, our model assigns each node two latent group memberships to flexibly capture asymmetric and heterogeneous interactions among users. These memberships, along with model parameters, can be consistently estimated using the proposed estimation procedure. As a result, the model performs node clustering and parameter estimation simultaneously, striking a balance between model flexibility and interpretability. We establish theoretical guarantees for the proposed method, showing that both group memberships and parameter estimators are consistent even when the number of groups is over-specified. When the group numbers are correctly specified, the parameter estimators are asymptotically normal, enabling valid statistical inference. In addition, we develop a quantile information criterion for the consistent selection of the number of groups. Simulation studies demonstrate strong finite-sample performance, and an application to Sina Weibo data illustrates the model’s ability to uncover behavioral dynamics and user interaction patterns. *(abstract via OpenAlex)*
SiM Survival Analysis Clinical Trials · 发表于 2026-09-14
Jingwen Zhang, Satoshi Hattori
摘要
It is common practice in randomized clinical trials with the standard survival outcome to follow patients until a prespecified number of events have been observed, a type of trial known as the event‐driven trial. The event‐driven design ensures that the target power for a specified Type I error rate is achieved to detect the target hazard ratio, regardless of the specification of other quantities. To understand the treatment effect for chronic conditions, the analysis of recurrent events has gained popularity in randomized controlled trials, particularly large‐scale confirmatory trials. In the absence of within‐subject correlation among multiple events, a similar event‐driven design can be employed for recurrent event outcomes. On the other hand, in the presence of within‐subject correlation, one needs to model the correlation among recurrent events in evaluating power and setting the sample size. However, information useful in modeling the within‐subject correlation is limited at the design stage. Failing to properly account for correlation may lead to underpowered studies. We propose an event‐driven type design for recurrent event outcomes. Our method ensures the target power for the target treatment effect, regardless of the specification of other quantities, by monitoring the robust variance under the marginal rates/means model in a blinded manner. We investigate the operating characteristics of the proposed monitoring procedure in simulation studies. The results of simulation studies showed that the proposed blinded monitoring procedure controlled the power well so that the test possessed the target power and did not lead to serious inflation of the Type I error rate. Furthermore, we illustrate the proposed method using a real clinical trial dataset.
SMMR Clinical Trials · 发表于 2026-09-14
Rosamarie Frieri, Francesco Mariani, Marco Novelli
摘要
We introduce a flexible adaptive design strategy for treatment allocation in clinical trials based on a randomized simulated annealing algorithm. The proposed approach provides a unified and modular framework for implementing a broad range of adaptive randomization objectives, including covariate-adaptive (CA), response-adaptive (RA), covariate-adjusted response-adaptive (CARA), and hybrid RA+CA and CARA+CA designs. The procedure accommodates multiple treatments, different outcome types, and any baseline covariate information available. Its implementation is compatible with both parametric and nonparametric predictive models; in this work, we use Bayesian additive regression trees to capture complex covariate-response relationships without committing to a low-dimensional parametric specification. The allocation rule combines a simulated-annealing-based recommendation with a fallback randomization step used to ensure positive assignment probabilities. In a finite stratified setting, we establish strong consistency of the resulting stratified sample mean estimators. Extensive simulation studies with homogeneous and heterogeneous treatment effects show that our proposal achieves a favorable trade-off between ethical allocation and statistical efficiency. A redesign of the ACTG 175 clinical trial further illustrates the practical advantages and flexibility of the proposed framework.
SMMR Diagnostics & Prediction · 发表于 2026-09-14
Tatiana Krikella, Joel A Dubin
摘要
Advances in precision medicine increasingly drive methodological innovation in health research. A key development is the use of personalized prediction models (PPMs) for a specific index patient, which are fit using a subpopulation similar to that index patient based on their covariates, and have been shown to outperform one-size-fits-all models, particularly in terms of model discrimination performance. We propose a generalized loss function that enables tuning of the subpopulation size used to fit a PPM. This loss function allows joint optimization of discrimination and calibration, allowing both the performance measures and their relative weights to be specified by the user. To reduce computational burden, we conducted extensive simulation studies to identify practical bounds for the grid of subpopulation sizes. Based on these results, we recommend using a lower bound of 20% and an upper bound of 70% of the entire training dataset. We apply the proposed method to both simulated and real-world datasets and demonstrate that previously observed relationships between subpopulation size and model performance are robust. Furthermore, we show that the choice of performance measures in the loss function influences the optimal subpopulation size selected. These findings support the flexible and computationally efficient implementation of PPMs in precision health research.
SMMR Clinical Trials · 发表于 2026-09-12
Arijit Dey, Xiaoxi Yan, Bibhas Chakraborty
摘要
With the rapid emergence of personalized healthcare, adaptive interventions have gained significant traction and relevance. Contemporary research has introduced a sophisticated trial design known as the sequential multiple assignment randomized trial (SMART) to advance the development of effective adaptive interventions. A critical element of the SMART design is the determination of the sample size. The existing literature provides sample size calculation formulas for SMART designs, which encompass a variety of approaches and types of outcome data. However, these formulas have primarily been developed under the assumption of normality for the outcome data. In practice, the fields where SMART is employed exhibit a significant prevalence of non-normality in the outcomes of interest. This paper delves into a specific scenario where the outcome demonstrates skewed behavior. We develop precision-based and power-based formulas for skewed outcomes, considering the requirements of both pilot and full-scale SMARTs. We present the operating characteristics of the formulas and perform extensive simulations under various design specifications to validate their usefulness. To demonstrate practical utility, we apply our formulas to the SMART+ study, a digital intervention trial that includes a skewed outcome among its outcomes of interest, highlighting relevance in real-world planning.
SMMR Survival Analysis · 发表于 2026-09-12
Ayoub Bifenzi, Helene Jacqmin-Gadda
摘要
In time-to-event analysis, the hazard ratio derived from the Cox proportional hazards model is the most commonly used and widely reported measure for assessing treatment effects. However, hazard ratios are non-collapsible due to their inherent conditioning on survival up to each time point. As a result, they are subject to built-in selection bias in the presence of unmeasured heterogeneity arising from omitted important covariates, even when these covariates are independent of the main exposure at baseline, as is the case in randomized controlled trials. This article aims to provide an overview of key findings from the literature on how unobserved heterogeneity, due to omitted covariates that affect the outcome, can bias the estimation of the treatment hazard ratio in standard proportional hazards models, even in randomized trials where treatment is assigned independently of such covariates. Through simulations, we evaluate the extent of bias in the semi-parametric Cox proportional hazards model and parametric proportional hazards model under various scenarios of unmeasured heterogeneity. We then compare these standard models to alternative approaches that either account for this issue or are considered robust to it. These alternatives include the hazard ratio estimated from frailty models, regression parameters from an accelerated failure time model, and survival differences between treatment groups estimated nonparametrically using Kaplan-Meier curves or based on a Cox model with time-dependent effect of the exposure. We illustrate the practical relevance of the explored alternatives through a real data application to a randomized controlled trial from the Radiation Therapy Oncology Group (RTOG9202).
SiM Causal Inference Bayesian Methods · 发表于 2026-09-11,收录于 2026-10-08
Se Yoon Lee
摘要
*(publisher's abstract as deposited in Crossref, verbatim)* Externally controlled single‐arm trials are increasingly popular because they do not require randomized controls, thereby substantially reducing financial costs; however, valid causal inference in this setting relies critically on transportability between the trial and external populations, an assumption that is untestable. Frequentist semiparametrically efficient estimators, such as the doubly robust estimator, are typically analyzed under first‐order asymptotics and are designed to mitigate nuisance‐estimation bias under correct specification; however, this framework does not account for structural bias arising under local transportability violations, where bias and stochastic fluctuation occur at the same parametric rate. We propose a reliable Bayesian framework for estimating the average treatment effect on the treated (ATT) that combines synthetic outcome construction with residualized power‐prior borrowing. Flexible machine learning is first used to construct covariate‐aligned synthetic controls, after which Bayesian inference on residualized outcomes allows external borrowing to modulate uncertainty without distorting covariate‐driven heterogeneity. The posterior admits a heavy‐tailed distribution—unlike classical Wald procedures—and the resulting estimator lies outside the class of regular asymptotically linear estimators, thereby revealing behavior beyond first‐order semiparametric asymptotics. We establish a reliability–efficiency trade‐off under local transportability violations. Simulations and a case study on schizophrenia trial design demonstrate the theoretical findings and practical utility.
JASA Meta-Analysis & Data Integration Functional Data · 发表于 2026-09-11
Gengyu Xue, Zhenhua Lin, Yi Yu
摘要
We systematically investigate the preservation of differential privacy in functional data analysis, beginning with functional mean estimation and extending to varying coefficient model estimation. Our work introduces a distributed learning framework involving multiple servers, each responsible for collecting several sparsely observed functions. This hierarchical setup introduces a mixed notion of privacy. Within each function, user-level differential privacy is applied to m discrete observations. At the server level, central differential privacy is deployed to account for the centralized nature of data collection. Across servers, only private information is exchanged, adhering to federated differential privacy constraints. To address this complex hierarchy, we employ minimax theory to reveal several fundamental phenomena: from sparse to dense FDA, from user-level to central and federated differential privacy costs, and the intricate interplay between different regimes of FDA and privacy preservation. To the best of our knowledge, this is the first study to rigorously examine functional data estimation under multiple privacy constraints. Our theoretical findings are complemented by efficient private algorithms and extensive numerical evidence, providing a comprehensive exploration of this challenging problem. *(abstract via OpenAlex)*
SiM Causal Inference Networks & Graphs High-Dimensional · 发表于 2026-09-11,收录于 2026-10-08
Jade Xiaoqing Wang et al.
摘要
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with survivors frequently experiencing long-term neurocognitive morbidities. Here, we utilize the TOTXVI clinical trial data to elucidate the mechanisms underlying treatment-related neurocognitive side effects in pediatric ALL patients by incorporating brain connectivity network data. To enable such analysis, we propose a high-dimensional mediation analysis method with a novel network mediation structural shrinkage (NMSS) prior, which is particularly suited for analyzing high-dimensional brain structural connectivity network data that serve as mediators. Our method is capable of addressing the structural dependencies of brain connectivity networks including sparsity, effective degrees of nodes, and modularity, yielding accurate estimates of the high-dimensional coefficients and mediation effects. We demonstrate the effectiveness and superiority of the proposed NMSS method through simulation studies and apply it to the TOTXVI data, revealing significant mediation effects of brain connectivity on visual processing speed directed by IT intensity. The findings shed light on the potential of targeted interventions to mitigate neurocognitive deficits in pediatric ALL survivors.